|
|
Volumn 30, Issue 2, 1999, Pages 579-581
|
|
Hepatitis B therapy: The plot thickens
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADEFOVIR;
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
CIRCULAR DNA;
DNA;
EMTRICITABINE;
ENTECAVIR;
FAMCICLOVIR;
HEPATITIS B(E) ANTIBODY;
HEPATITIS B(E) ANTIGEN;
INTERFERON;
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS DNA;
CLINICAL TRIAL;
DNA REPLICATION;
DRUG EFFICACY;
DRUG POTENCY;
DRUG SAFETY;
EDITORIAL;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HYBRIDIZATION;
ORAL DRUG ADMINISTRATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SEROCONVERSION;
VIRUS GENOME;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HEPATITIS D, CHRONIC;
HUMANS;
LAMIVUDINE;
MUTATION;
|
|
EID: 0032793599
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1002/hep.510300238 Document Type: Editorial |
|
Times cited : (29)
|
|
References (31)
|
